The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methionine for Pharmaceutical Market Research Report 2025
Synopsis
Methionine is a protein-based amino acid and lipotropic compound that helps with metabolism and breaks down fat. It contains α-amino group, α-carboxylic acid group and an S-methyl thioether side chain. Methionine is classed as an essential amino acid and cannot be synthesized by the body itself.
The global Methionine for Pharmaceutical market was valued at US$ 158 million in 2023 and is anticipated to reach US$ 238.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Methionine for Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methionine for Pharmaceutical.
Report Scope
The Methionine for Pharmaceutical market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methionine for Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methionine for Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evonik
Adisseo (Bluestar)
NOVUS
Sumitomo Chemical
CJ Cheiljedang Corp
Chongqing Unisplendour Chemical
Sichuan Hebang
Segment by Type
Liquid Methionine
Solid Methionine
Segment by Application
Tablets
Liquid
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methionine for Pharmaceutical manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Methionine for Pharmaceutical by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Methionine for Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Methionine is a protein-based amino acid and lipotropic compound that helps with metabolism and breaks down fat. It contains α-amino group, α-carboxylic acid group and an S-methyl thioether side chain. Methionine is classed as an essential amino acid and cannot be synthesized by the body itself.
The global Methionine for Pharmaceutical market was valued at US$ 158 million in 2023 and is anticipated to reach US$ 238.3 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Methionine for Pharmaceutical, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methionine for Pharmaceutical.
Report Scope
The Methionine for Pharmaceutical market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methionine for Pharmaceutical market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methionine for Pharmaceutical manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Evonik
Adisseo (Bluestar)
NOVUS
Sumitomo Chemical
CJ Cheiljedang Corp
Chongqing Unisplendour Chemical
Sichuan Hebang
Segment by Type
Liquid Methionine
Solid Methionine
Segment by Application
Tablets
Liquid
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methionine for Pharmaceutical manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Methionine for Pharmaceutical by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Methionine for Pharmaceutical in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Methionine for Pharmaceutical Market Overview
1.1 Product Definition
1.2 Methionine for Pharmaceutical Segment by Type
1.2.1 Global Methionine for Pharmaceutical Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Liquid Methionine
1.2.3 Solid Methionine
1.3 Methionine for Pharmaceutical Segment by Application
1.3.1 Global Methionine for Pharmaceutical Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablets
1.3.3 Liquid
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Methionine for Pharmaceutical Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Methionine for Pharmaceutical Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Methionine for Pharmaceutical Production Estimates and Forecasts (2019-2030)
1.4.4 Global Methionine for Pharmaceutical Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Methionine for Pharmaceutical Production Market Share by Manufacturers (2019-2024)
2.2 Global Methionine for Pharmaceutical Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Methionine for Pharmaceutical, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Methionine for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Methionine for Pharmaceutical Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Methionine for Pharmaceutical, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Methionine for Pharmaceutical, Product Offered and Application
2.8 Global Key Manufacturers of Methionine for Pharmaceutical, Date of Enter into This Industry
2.9 Methionine for Pharmaceutical Market Competitive Situation and Trends
2.9.1 Methionine for Pharmaceutical Market Concentration Rate
2.9.2 Global 5 and 10 Largest Methionine for Pharmaceutical Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Methionine for Pharmaceutical Production by Region
3.1 Global Methionine for Pharmaceutical Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Methionine for Pharmaceutical Production Value by Region (2019-2030)
3.2.1 Global Methionine for Pharmaceutical Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Methionine for Pharmaceutical by Region (2025-2030)
3.3 Global Methionine for Pharmaceutical Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Methionine for Pharmaceutical Production by Region (2019-2030)
3.4.1 Global Methionine for Pharmaceutical Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Methionine for Pharmaceutical by Region (2025-2030)
3.5 Global Methionine for Pharmaceutical Market Price Analysis by Region (2019-2024)
3.6 Global Methionine for Pharmaceutical Production and Value, Year-over-Year Growth
3.6.1 North America Methionine for Pharmaceutical Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Methionine for Pharmaceutical Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Methionine for Pharmaceutical Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Methionine for Pharmaceutical Production Value Estimates and Forecasts (2019-2030)
4 Methionine for Pharmaceutical Consumption by Region
4.1 Global Methionine for Pharmaceutical Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Methionine for Pharmaceutical Consumption by Region (2019-2030)
4.2.1 Global Methionine for Pharmaceutical Consumption by Region (2019-2024)
4.2.2 Global Methionine for Pharmaceutical Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Methionine for Pharmaceutical Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Methionine for Pharmaceutical Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Methionine for Pharmaceutical Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Methionine for Pharmaceutical Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Methionine for Pharmaceutical Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Methionine for Pharmaceutical Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Methionine for Pharmaceutical Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Methionine for Pharmaceutical Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Methionine for Pharmaceutical Production by Type (2019-2030)
5.1.1 Global Methionine for Pharmaceutical Production by Type (2019-2024)
5.1.2 Global Methionine for Pharmaceutical Production by Type (2025-2030)
5.1.3 Global Methionine for Pharmaceutical Production Market Share by Type (2019-2030)
5.2 Global Methionine for Pharmaceutical Production Value by Type (2019-2030)
5.2.1 Global Methionine for Pharmaceutical Production Value by Type (2019-2024)
5.2.2 Global Methionine for Pharmaceutical Production Value by Type (2025-2030)
5.2.3 Global Methionine for Pharmaceutical Production Value Market Share by Type (2019-2030)
5.3 Global Methionine for Pharmaceutical Price by Type (2019-2030)
6 Segment by Application
6.1 Global Methionine for Pharmaceutical Production by Application (2019-2030)
6.1.1 Global Methionine for Pharmaceutical Production by Application (2019-2024)
6.1.2 Global Methionine for Pharmaceutical Production by Application (2025-2030)
6.1.3 Global Methionine for Pharmaceutical Production Market Share by Application (2019-2030)
6.2 Global Methionine for Pharmaceutical Production Value by Application (2019-2030)
6.2.1 Global Methionine for Pharmaceutical Production Value by Application (2019-2024)
6.2.2 Global Methionine for Pharmaceutical Production Value by Application (2025-2030)
6.2.3 Global Methionine for Pharmaceutical Production Value Market Share by Application (2019-2030)
6.3 Global Methionine for Pharmaceutical Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Evonik
7.1.1 Evonik Methionine for Pharmaceutical Corporation Information
7.1.2 Evonik Methionine for Pharmaceutical Product Portfolio
7.1.3 Evonik Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Evonik Main Business and Markets Served
7.1.5 Evonik Recent Developments/Updates
7.2 Adisseo (Bluestar)
7.2.1 Adisseo (Bluestar) Methionine for Pharmaceutical Corporation Information
7.2.2 Adisseo (Bluestar) Methionine for Pharmaceutical Product Portfolio
7.2.3 Adisseo (Bluestar) Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Adisseo (Bluestar) Main Business and Markets Served
7.2.5 Adisseo (Bluestar) Recent Developments/Updates
7.3 NOVUS
7.3.1 NOVUS Methionine for Pharmaceutical Corporation Information
7.3.2 NOVUS Methionine for Pharmaceutical Product Portfolio
7.3.3 NOVUS Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.3.4 NOVUS Main Business and Markets Served
7.3.5 NOVUS Recent Developments/Updates
7.4 Sumitomo Chemical
7.4.1 Sumitomo Chemical Methionine for Pharmaceutical Corporation Information
7.4.2 Sumitomo Chemical Methionine for Pharmaceutical Product Portfolio
7.4.3 Sumitomo Chemical Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Sumitomo Chemical Main Business and Markets Served
7.4.5 Sumitomo Chemical Recent Developments/Updates
7.5 CJ Cheiljedang Corp
7.5.1 CJ Cheiljedang Corp Methionine for Pharmaceutical Corporation Information
7.5.2 CJ Cheiljedang Corp Methionine for Pharmaceutical Product Portfolio
7.5.3 CJ Cheiljedang Corp Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.5.4 CJ Cheiljedang Corp Main Business and Markets Served
7.5.5 CJ Cheiljedang Corp Recent Developments/Updates
7.6 Chongqing Unisplendour Chemical
7.6.1 Chongqing Unisplendour Chemical Methionine for Pharmaceutical Corporation Information
7.6.2 Chongqing Unisplendour Chemical Methionine for Pharmaceutical Product Portfolio
7.6.3 Chongqing Unisplendour Chemical Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Chongqing Unisplendour Chemical Main Business and Markets Served
7.6.5 Chongqing Unisplendour Chemical Recent Developments/Updates
7.7 Sichuan Hebang
7.7.1 Sichuan Hebang Methionine for Pharmaceutical Corporation Information
7.7.2 Sichuan Hebang Methionine for Pharmaceutical Product Portfolio
7.7.3 Sichuan Hebang Methionine for Pharmaceutical Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Sichuan Hebang Main Business and Markets Served
7.7.5 Sichuan Hebang Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Methionine for Pharmaceutical Industry Chain Analysis
8.2 Methionine for Pharmaceutical Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Methionine for Pharmaceutical Production Mode & Process
8.4 Methionine for Pharmaceutical Sales and Marketing
8.4.1 Methionine for Pharmaceutical Sales Channels
8.4.2 Methionine for Pharmaceutical Distributors
8.5 Methionine for Pharmaceutical Customers
9 Methionine for Pharmaceutical Market Dynamics
9.1 Methionine for Pharmaceutical Industry Trends
9.2 Methionine for Pharmaceutical Market Drivers
9.3 Methionine for Pharmaceutical Market Challenges
9.4 Methionine for Pharmaceutical Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
